Menu Search
Equities

Bastide le Confort Medical SA

1DJ:DEU

Bastide le Confort Medical SA

Actions
  • Price (EUR)19.66
  • Today's Change0.10 / 0.51%
  • Shares traded0.00
  • 1 Year change-30.16%
  • Beta--
Data delayed at least 15 minutes, as of May 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Bastide le Confort Medical SA is a France-based company specializes in home health services for the elderly, ill, and handicapped. The Company activity is organized around three families of products and services such as home care equipment and services, respiratory assistance equipment and services, perfusion and nutrition equipment and services, It provides hospital beds, personal assistance products, etc. The Company provides mainly respirators, oxygen concentrators, and oxygen tanks; The offers perfusion, nutrition, and insulin pumps and syringe-drivers. It offers devices to support diabetic patients towards daily comfort and a normal life. The Company offers wide range of products and services to relieve patients losing their autonomy. It fer tailor-made, solutions for a secure, humane, and deeply respectful care pathway.

  • Revenue in EUR (TTM)523.32m
  • Net income in EUR6.32m
  • Incorporated1976
  • Employees3.55k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		BLC:PAR since
announced		Transaction
value
OxigoDeal completed01 Jul 202301 Jul 2023Deal completed-31.33%--
Occit PerfDeal completed01 Jul 202301 Jul 2023Deal completed-31.33%--
Data delayed at least 15 minutes, as of May 09 2024 12:52 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.